Expected impact of MRI related interreader variability on ProScreen prostate cancer screening trial

Expected impact of MRI related interreader variability on ProScreen prostate cancer screening trial

Bibliographic Details
Main Authors:	R. Hietikko, T.P. Kilpeläinen, A. Kenttämies, J. Ronkainen, K. Ijäs, K. Lind, S. Marjasuo, J. Oksala, O. Oksanen, T. Saarinen, R. Savolainen, K. Taari, T.L.J. Tammela, T. Mirtti, K. Natunen, A. Auvinen, A. Rannikko
Format:	Article
Language:	English
Published:	Elsevier 2020-07-01
Series:	European Urology Open Science
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666168320326562

Similar Items

Expected impact of MRI-related interreader variability on ProScreen prostate cancer screening trial: a pre-trial validation study
by: Ronja Hietikko, et al.
Published: (2020-10-01)

Early detection of clinically significant prostate cancer: protocol summary and statistical analysis plan for the ProScreen randomised trial
by: Jaakko Nevalainen, et al.
Published: (2024-01-01)

Outcomes of prostate cancer screening among men using antidiabetic medication
by: A. Vettenranta, et al.
Published: (2021-04-01)

Non-Steroidal Anti-Inflammatory Drugs and Cancer Death in the Finnish Prostate Cancer Screening Trial.
by: Thea Veitonmäki, et al.
Published: (2016-01-01)

Prostate cancer-specific survival among warfarin users in the Finnish Randomized Study of Screening for Prostate Cancer
by: Pete T. T. Kinnunen, et al.
Published: (2017-08-01)

Prostate MRI added to CAPRA, MSKCC and Partin cancer nomograms significantly enhances the prediction of adverse findings and biochemical recurrence after radical prostatectomy.
by: Kevin Sandeman, et al.
Published: (2020-01-01)

Histomic and transcriptomic features of MRI-visible and invisible clinically significant prostate cancers are associated with prognosis
by: Lehto, T-PK, et al.
Published: (2023)

Charlson Comorbidity Index Based On Hospital Episode Statistics Performs Adequately In Predicting Mortality, But Its Discriminative Ability Diminishes Over Time
by: Pylväläinen J, et al.
Published: (2019-10-01)

Statin use and outcomes of oncological treatment for castration-resistant prostate cancer
by: A. I. Peltomaa, et al.
Published: (2023-11-01)

Prognostic Index for Predicting Prostate Cancer Survival in a Randomized Screening Trial: Development and Validation
by: Subas Neupane, et al.
Published: (2021-01-01)

Cost-effectiveness analysis of PSA-based mass screening: Evidence from a randomised controlled trial combined with register data.
by: Neill Booth, et al.
Published: (2019-01-01)

Long‐term health‐related quality of life among men with prostate cancer in the Finnish randomized study of screening for prostate cancer
by: Kirsi Talala, et al.
Published: (2020-08-01)

Diagnostic Value and Interreader Agreement of the Pancreaticolienal Gap in Pancreatic Cancer on MDCT.
by: Khoschy Schawkat, et al.
Published: (2016-01-01)

Reticular Pseudodrusen: Interreader Agreement of Evaluation on OCT Imaging in Age-Related Macular Degeneration
by: Zhichao Wu, BAppSc(Optom), PhD, et al.
Published: (2023-12-01)

Editorial Comment: A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer
by: J Hugosson, et al.
Published: (2020-03-01)

Antihypertensive drug use and prostate cancer-specific mortality in Finnish men.
by: Aino Siltari, et al.
Published: (2020-01-01)

Interreader Reliability of Liver Imaging Reporting and Data System Treatment Response: A Systematic Review and Meta-Analysis
by: Dong Wook Kim, et al.
Published: (2021-02-01)

Inverse Association between Statin Use and Cancer Mortality Relates to Cholesterol Level
by: Antti I. Peltomaa, et al.
Published: (2022-06-01)

Test sensitivity in the European prostate cancer screening trial: results from Finland, Sweden, and the Netherlands.
by: Auvinen, A, et al.
Published: (2009)

Genotyped functional screening of soluble Fab clones enables in-depth analysis of mutation effects
by: Sami Oksanen, et al.
Published: (2023-08-01)

68Ga-PSMA-11 PET/MRI versus multiparametric MRI in men referred for prostate biopsy: primary tumour localization and interreader agreement
by: Daniela A. Ferraro, et al.
Published: (2022-07-01)

Analysis of interreader agreement in structured reports of pelvic multiparametric magnetic resonance imaging using the METastasis Reporting and Data System for Prostate Cancer guidelines
by: Xiang Liu, et al.
Published: (2023-01-01)

Spectral decoupling for training transferable neural networks in medical imaging
by: Joona Pohjonen, et al.
Published: (2022-02-01)

Interreader reproducibility of the Neck Imaging Reporting and Data system (NI-RADS) lexicon for the detection of residual/recurrent disease in treated head and neck squamous cell carcinoma (HNSCC)
by: Tougan Taha Abdelaziz, et al.
Published: (2020-08-01)

Polymorph Screening Technology by Controlling Crystallization
by: J. Mensah, et al.
Published: (2013-06-01)

REFRACTIVE SCREENING OF INFANTS
by: Atkinson, J, et al.
Published: (1982)

Interreader agreement in different PI-RADS systems in multiparametric prostate magnetic resonance imaging: A head-to-head comparison between PI-RADSv2 and v2.1
by: Merve Horoz, et al.
Published: (2021-01-01)

Refractive screening in infants.
by: Atkinson, J, et al.
Published: (1982)

Intervention-related Deaths in the European Randomized Study of Screening for Prostate Cancer
by: Rebecka Arnsrud Godtman, et al.
Published: (2021-12-01)

Cancer screening simulation models: a state of the art review
by: Aleksandr Bespalov, et al.
Published: (2021-12-01)

Screening
by: Dina A. Ghoraba, et al.
Published: (2014-01-01)

Screening for mild cognitive impairment: a systematic review.
by: Lonie, J, et al.
Published: (2009)

School screening for scoliosis
by: K. Connellan
Published: (2000-11-01)

Screening and characterisation of antimicrobial properties of semisynthetic betulin derivatives.
by: Shafiul Haque, et al.
Published: (2014-01-01)

Screening and prostate-cancer mortality in a randomized European study.
by: Schröder, F, et al.
Published: (2009)

Use of research questionnaires in the NHS Bowel Cancer Screening Programme in England: impact on screening uptake.
by: Watson, J, et al.
Published: (2013)

Nuorten vaihtoehtoliikunta yhteisöllisen kasvun ja oppimisen mahdollistajana
by: Anni Rannikko, et al.
Published: (2014-09-01)

Screening door Europese incubators
by: K. Aerts, et al.
Published: (2004-01-01)

Allergy: Screening and occupational asthma
by: Venables, K
Published: (1996)

Differential Predictive Roles of A- and B-Type Nuclear Lamins in Prostate Cancer Progression.
by: Irena Saarinen, et al.
Published: (2015-01-01)